MeSH D009182 - mycosis fungoides
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Etoposide | Etoposide |  | 1994-02-10 |  |  |
| Cyclophosphamide | Neosar |  | 1993-04-29 |  |  | |
| Etoposide | Toposar |  | 1995-02-27 |  |  | |
| Ingenus | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 |  |  |
| Mylan | Etoposide | Etoposide |  | 2001-09-19 |  |  |
| Methotrexate | Methotrexate |  | 1992-05-15 |  |  | |
| Roche | Ribavirin, Peginterferon alfa-2a | Pegasys Copegus |  | 2004-06-04 |  |  |
| Interferon alfa-2a | Roferon-A |  | 1986-06-04 |  |  | |
| Cipla | Cyclophosphamide | Cyclophosphamide |  | 2019-01-18 |  |  |
| Sandoz | Cyclophosphamide | Cyclophosphamide |  | 2023-09-12 |  |  |
| Methotrexate | Methotrexate |  | 2009-03-31 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
39%18/46
Phase 2
7%2/28
Phase 3
86%25/29
Approved: 23Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use